Literature DB >> 2771174

Postischemic moderate hypothermia inhibits CA1 hippocampal ischemic neuronal injury.

R Busto1, W D Dietrich, M Y Globus, M D Ginsberg.   

Abstract

We have determined whether lowering brain temperature during the acute recirculation period following transient cerebral ischemia would influence the extent of ischemic neuronal injury. Anesthetized rats underwent 10 min of bilateral carotid artery occlusion combined with systemic hypotension (50 mmHg). Four animal subgroups were investigated, including non-ischemic controls; rats whose postischemic brain temperature was maintained at 36 or 30 degrees C starting 5 min into the recirculation period; and rats in which postischemic hypothermia was begun 30 min into the recirculation period. In all cases, intra-ischemic brain temperature was 36 degrees C and body temperature was held at 36-37 degrees C throughout. Three days following the ischemic insult, the CA1 sector of the hippocampus was severely damaged in normothermic rats (36 degrees C). In contrast, when postischemic brain temperature was decreased to 30 degrees C starting 5 min into the recirculation period, normal-appearing pyramidal neurons were present throughout the CA1 hippocampus. A beneficial effect of postischemic hypothermia was not demonstrated when brain cooling was initiated 30 min into the recirculation period. These results demonstrate that postischemic hypothermia can markedly protect CA1 pyramidal neurons from injury following transient ischemia. The 'therapeutic window' for postischemic hypothermia was found to be narrow under the present experimental conditions.

Entities:  

Mesh:

Year:  1989        PMID: 2771174     DOI: 10.1016/0304-3940(89)90549-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  52 in total

1.  Therapeutic applications of hypothermia in cerebral ischaemia.

Authors:  Bruno P Meloni; Frank L Mastaglia; Neville W Knuckey
Journal:  Ther Adv Neurol Disord       Date:  2008-09       Impact factor: 6.570

2.  Mild hypothermia decreases GSK3beta expression following global cerebral ischemia.

Authors:  Stephen Kelly; Danye Cheng; Gary K Steinberg; Midori A Yenari
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

3.  Fever control and application of hypothermia using intravenous cold saline.

Authors:  Ericka L Fink; Patrick M Kochanek; Robert S B Clark; Michael J Bell
Journal:  Pediatr Crit Care Med       Date:  2012-01       Impact factor: 3.624

4.  Posthypoxic cooling of neonatal rats provides protection against brain injury.

Authors:  M Thoresen; R Bågenholm; E M Løberg; F Apricena; I Kjellmer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-01       Impact factor: 5.747

5.  [Endovascular or surface cooling?: therapeutic hypothermia after cardiac arrest].

Authors:  K Fink; T Schwab; C Bode; H-J Busch
Journal:  Anaesthesist       Date:  2008-12       Impact factor: 1.041

6.  The influence of hypothermia on hypoglycemia-induced brain damage in the rat.

Authors:  C D Agardh; M L Smith; B K Siesjö
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 7.  Calcium, energy metabolism and the development of selective neuronal loss following short-term cerebral ischemia.

Authors:  N R Sims
Journal:  Metab Brain Dis       Date:  1995-09       Impact factor: 3.584

Review 8.  Hypothermia for neuroprotection in children after cardiopulmonary arrest.

Authors:  Barnaby Scholefield; Heather Duncan; Paul Davies; Fang Gao Smith; Khalid Khan; Gavin D Perkins; Kevin Morris
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

Review 9.  Combination therapy with hypothermia for treatment of cerebral ischemia.

Authors:  Xian N Tang; Liping Liu; Midori A Yenari
Journal:  J Neurotrauma       Date:  2009-03       Impact factor: 5.269

10.  Using diffusion MRI for measuring the temperature of cerebrospinal fluid within the lateral ventricles.

Authors:  L R Kozak; M Bango; M Szabo; G Rudas; Z Vidnyanszky; Z Nagy
Journal:  Acta Paediatr       Date:  2009-10-20       Impact factor: 2.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.